These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 21943108)
1. A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization. Palmer GM; Tiran Z; Zhou Z; Capozzi ME; Park W; Coletta C; Pyriochou A; Kliger Y; Levy O; Borukhov I; Dewhirst MW; Rotman G; Penn JS; Papapetropoulos A Br J Pharmacol; 2012 Mar; 165(6):1891-1903. PubMed ID: 21943108 [TBL] [Abstract][Full Text] [Related]
2. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization. Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816 [No Abstract] [Full Text] [Related]
3. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2. Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027 [TBL] [Abstract][Full Text] [Related]
4. Novel Peptide NT/K-CRS Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y J Ocul Pharmacol Ther; 2021 Sep; 37(7):412-420. PubMed ID: 34252290 [No Abstract] [Full Text] [Related]
5. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis. Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737 [No Abstract] [Full Text] [Related]
6. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects. Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666 [TBL] [Abstract][Full Text] [Related]
7. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects. Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033 [TBL] [Abstract][Full Text] [Related]
8. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo. Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024 [TBL] [Abstract][Full Text] [Related]
9. β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models. Dahham SS; Tabana Y; Asif M; Ahmed M; Babu D; Hassan LE; Ahamed MBK; Sandai D; Barakat K; Siraki A; Majid AMSA Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638895 [TBL] [Abstract][Full Text] [Related]
11. Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model. Tabana YM; Hassan LE; Ahamed MB; Dahham SS; Iqbal MA; Saeed MA; Khan MS; Sandai D; Majid AS; Oon CE; Majid AM Microvasc Res; 2016 Sep; 107():17-33. PubMed ID: 27133199 [TBL] [Abstract][Full Text] [Related]
12. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature. Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566 [TBL] [Abstract][Full Text] [Related]
13. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632 [TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis. Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382 [TBL] [Abstract][Full Text] [Related]
16. Novel peptide derived from IGF-2 displays anti-angiogenic activity in vitro and inhibits retinal angiogenesis in a model of oxygen-induced retinopathy. Zheng Y; Sun Q; Xu X; Wang W Clin Exp Ophthalmol; 2020 Dec; 48(9):1261-1275. PubMed ID: 33026147 [TBL] [Abstract][Full Text] [Related]
17. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101 [TBL] [Abstract][Full Text] [Related]
18. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424 [TBL] [Abstract][Full Text] [Related]
19. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways. Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330 [TBL] [Abstract][Full Text] [Related]
20. Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth. Lai KC; Hsu SC; Yang JS; Yu CC; Lein JC; Chung JG J Cell Mol Med; 2015 Feb; 19(2):474-84. PubMed ID: 25403643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]